Bragar Eagel & Squire, P.C. announced that a class-action lawsuit was filed against PROCEPT BioRobotics Corporation in the United States District Court for the Northern District of California. The case covers investors who purchased or otherwise acquired Procept common stock between February 28, 2024, and February 25, 2026, inclusive. Investors have until September 22, 2026, to ask the court to appoint them as lead plaintiff, the investor who represents the proposed class. The lawsuit alleges that Procept used an undisclosed discount program to encourage bulk customer orders beyond procedure demand, pulling sales forward and overstating U.S. handpiece unit sales and revenue. It further alleges that orders exceeded underlying demand, creating more than 10,000 excess handpiece units in customer inventories by the end of the Class Period. The complaint claims Procept therefore overstated handpiece sales and utilization of its field Systems, faced undisclosed operational and financial risks, and lacked a reasonably achievable factual basis for its 2025 handpiece sales and revenue guidance. The law firm says investors suffered losses when the alleged details became known and is offering consultations at no cost or obligation.